GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanai Health Industry Group Co Ltd (OTCPK:SHIGF) » Definitions » Quality Rank

SHIGF (Sanai Health Industry Group Co) Quality Rank


View and export this data going back to 2008. Start your Free Trial

What is Sanai Health Industry Group Co Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Sanai Health Industry Group Co Quality Rank Related Terms

Thank you for viewing the detailed overview of Sanai Health Industry Group Co's Quality Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanai Health Industry Group Co Business Description

Traded in Other Exchanges
Address
57 Hung To Road, Unit 5, 7th Floor, Nanyang Plaza, Kwun Tong, Kowloon, Hong Kong, HKG
Sanai Health Industry Group Co Ltd is a pharmaceutical company. The company has three reportable segments namely Pharmaceutical products includes development, manufacturing, marketing and sales of pharmaceutical products and related software and provision of consultancy services. Finance leasing includes the provision of financial leasing services; Genetic testing and molecular diagnostic services segment. It generates maximum revenue from Pharmaceutical products segments. Geographically, it derives a majority revenue from PRC.